Connect Sign In
Kanako Yumioka’s journey from Housekeeping to Specimen Processing shows how mentorship, support, and a “warmful” culture help employees grow and find their path at ARUP Laboratories.
The ARUP Consult Colorectal Cancer topic highlights updated screening recommendations and guidance to help clinicians choose appropriate tests for early detection.
ARUP research highlights include cytogenetic abnormalities of pediatric B-cell acute lymphoblastic leukemia, pharmacogenomic testing, and the influence of diet on biochemical genetic testing.
Tracy George, MD, is a champion for patients with rare and undiagnosed conditions and will speak about ARUP’s innovative efforts that support the rare disease community.
ARUP’s Innovation Central Laboratory will serve as an ecosystem for validating technologies and accelerating next generation diagnostics from concept to commercialization.
Healthcare Advisory Services Vice President Sandy Richman will present strategies for hospital laboratories to launch or grow successful outreach programs and become strategic health system partners.
Ryan Metcalf, MD, CQA(ASQ), has been named to ABPath’s Test Development and Advisory Committee for Blood Banking and Transfusion Medicine, a recognition of his expertise and leadership in the field.
ARUP scientists authored more than 130 peer-reviewed publications and presented at over 100 conferences in 2025, highlighting a year of research, innovation, and progress in diagnostic medicine.
ARUP is the first U.S. lab to validate Rarity Bioscience’s ultrasensitive superRCA™ assay, which advances high-precision mutation detection and supports innovation in clinical and trial settings.
The Winter 2026 Edition of ARUP’s Magnify Magazine Is Now Available and Focuses on Pediatric Testing
ARUP has built a comprehensive pediatric test menu and paired it with research, education, and expert consultation to help care teams make informed decisions for children.
New ADLM guidance helps emergency department providers choose and interpret urine drug tests, highlighting current methods, limitations, and recommended drug classes.
During Cervical Cancer Awareness Month, ARUP Consult® highlights self-collected vaginal specimen testing as an FDA-approved, guideline-supported option to help address HPV screening barriers.
